# Pierre Fabre signs XtalPi agreement for AI and robotics drug discovery

_Published Monday, November 9, 2026 at 5:18 AM EST · AI · Latest · Tier 2 — Notable_

![Pierre Fabre signs XtalPi agreement for AI and robotics drug discovery — Primary](https://s.yimg.com/lo/mysterio/api/6af9d8d4b5bec47961a314b70bcbbdb77179ca9dfd127a1e2a91bc4d876c701a/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fprnewswire.com%2Fafad6463bf465f979159a574ec5e8749.jpg)

Laboratoires Pierre Fabre and XtalPi announced an agreement on November 9 to discover small-molecule drug candidates across multiple research programs in oncology, potentially dermatology, and rare diseases. XtalPi will use AI and robotics to design new molecules against undisclosed targets.

Pierre Fabre will select and advance promising compounds and take responsibility for subsequent clinical and commercial development. The agreement includes an upfront payment, multiple milestone payments and downstream economic participation; the companies did not disclose specific financial terms.

## Sources

- [Yahoo Finance](https://finance.yahoo.com/healthcare/articles/laboratoires-pierre-fabre-xtalpi-announce-093000880.html)

---
Canonical: https://techandbusiness.org/newswire/Q7e2NbjffQNsyrrAPlmVTB
Published: 2026-11-09T10:18:15.333Z
Story chronology: 2026-11-09T09:30:00.000Z
Retrieved: 2026-11-09T12:10:50.098Z
Publisher: Tech & Business (techandbusiness.org)